Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shikoku Kasei Holdings is a Japanese chemical manufacturer that provides advanced materials and fine chemicals for various industrial and life science applications. The company is a leading producer of imidazole derivatives, which serve as critical intermediates in the synthesis of pharmaceuticals and as curing agents for epoxy resins. In the healthcare sector, they also manufacture chlorinated isocyanurates used for water purification and sanitization under the Neo-Chlor brand. Their Life Science business segment integrates these chemical technologies to address global needs in health, hygiene, and environmental protection. Following a transition to a holding company structure in 2023, the firm continues to expand its global footprint in the specialty chemicals market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shikoku Kasei Holdings.